BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Homology Medicines Inc. (FIXX) on Thursday reported a loss of $34.3 million in its fourth quarter.
The Bedford, Massachusetts-based company said it had a loss of 60 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.
The gene editing company posted revenue of $802,000 in the period.
For the year, the company reported that its loss narrowed to $5 million, or 9 cents per share. Revenue was reported as $3.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
